SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001437749-13-004327
Filing Date
2013-04-11
Accepted
2013-04-11 16:31:22
Documents
3
Period of Report
2013-05-24
Effectiveness Date
2013-04-11

Document Format Files

Seq Description Document Type Size
1 DEF 14A furx_def14a-052413.htm DEF 14A 656048
2 sig1.jpg GRAPHIC 5147
3 img1.jpg GRAPHIC 224678
  Complete submission text file 0001437749-13-004327.txt   974086
Mailing Address 3900 PARAMOUNT PARKWAY SUITE 150 MORRISVILLE NC 27560
Business Address 3900 PARAMOUNT PARKWAY SUITE 150 MORRISVILLE NC 27560 919-456-7800
Furiex Pharmaceuticals, Inc. (Filer) CIK: 0001484478 (see all company filings)

IRS No.: 271197863 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-34641 | Film No.: 13756532
SIC: 2834 Pharmaceutical Preparations